|

Study on the Detection of Pleuropulmonary Manifestations in Rheumatoid Arthritis

RECRUITINGSponsored by Medical University Innsbruck
Actively Recruiting
SponsorMedical University Innsbruck
Started2024-11-11
Est. completion2028-05-30
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06965322

Summary

The aim of the study is to develop a standardized, risk-adapted screening protocol for detecting pleuropulmonary manifestations in patients with rheumatoid arthritis. To assess the risk of these manifestations, a comprehensive range of functional and clinical evaluations will be performed and correlated with structural lung assessments using computed tomography (CT).

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients ≥18 years diagnosed with rheumatoid arthritis according to current ACR/EULAR criteria
* Residence in Austria
* Signed and dated consent of the patient in accordance with ICH-GCP guidelines

Exclusion Criteria:

* pregnancy
* age below 18 years
* Contraindications to study-related routine examinations (e.g., inability to draw blood due to needle phobia, no CT scan possible due to claustrophobia, pregnancy, etc.)

Conditions3

ArthritisInterstitial Lung Disease in Patients With Rheumatoid ArthritisRheumatic Arthritis

Browse More Trials

Arthritis trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.